BTC Proponents Cite Pharmacists’ Role; Opponents Question Need
This article was originally published in The Tan Sheet
Executive Summary
There is one thing agreed on by opponents and proponents of assigning drugs to behind-the-counter status, including representatives from the pharmaceutical industry, drug retailers, the pharmacy and medical professions, researchers and consumer advocates: FDA will need a long time to reach a decision on the issue, they say
You may also be interested in...
Incoming CHPA Head Melville Brings Pharma Resume To OTC Learning Curve
The Consumer Healthcare Products Association's next president, Scott Melville, says his Rx manufacturing and distribution experience provides a foundation for "navigating a complex regulatory structure" in his first position on the OTC side of the drug industry.
Incoming CHPA Head Melville Brings Pharma Resume To OTC Learning Curve
The Consumer Healthcare Products Association's next president, Scott Melville, says his Rx manufacturing and distribution experience provides a foundation for "navigating a complex regulatory structure" in his first position on the OTC side of the drug industry.
Incoming CHPA Head Melville Brings Pharma Resume To OTC Learning Curve
The Consumer Healthcare Products Association's next president, Scott Melville, says his Rx manufacturing and distribution experience provides a foundation for "navigating a complex regulatory structure" in his first position on the OTC side of the drug industry.